Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-25-000092
Filing Date
2025-05-06
Accepted
2025-05-06 16:02:49
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20250331.htm   iXBRL 10-Q 833739
2 EX-31.1 exhibit311ceoq12025.htm EX-31.1 10826
3 EX-31.2 exhibit312cfoq12025.htm EX-31.2 10794
4 EX-32.1 exhibit321ceocfoq12025.htm EX-32.1 6982
  Complete submission text file 0001787306-25-000092.txt   5835690

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20250331.xsd EX-101.SCH 44477
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20250331_cal.xml EX-101.CAL 63803
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20250331_def.xml EX-101.DEF 202314
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20250331_lab.xml EX-101.LAB 611213
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20250331_pre.xml EX-101.PRE 414803
70 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20250331_htm.xml XML 722439
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 25917119
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)